effects of enteral l-arginine to decrease feeding intolerance and risk of NEC in neonates via
its role as a NO precursor. Also, enteral glutamine which may play a role as an
immunomodulator on preterm neonates. all these had never been studied in developing countries
where sepsis and nec act as a major participant in mortality rates.